PortfoliosLab logo
IBRX vs. ACIC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IBRX and ACIC is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

IBRX vs. ACIC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ImmunityBio, Inc. (IBRX) and American Coastal Insurance Corp (ACIC). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-92.67%
-11.22%
IBRX
ACIC

Key characteristics

Sharpe Ratio

IBRX:

-0.70

ACIC:

0.33

Sortino Ratio

IBRX:

-1.04

ACIC:

0.88

Omega Ratio

IBRX:

0.88

ACIC:

1.11

Calmar Ratio

IBRX:

-0.72

ACIC:

0.26

Martin Ratio

IBRX:

-1.23

ACIC:

1.00

Ulcer Index

IBRX:

55.45%

ACIC:

15.92%

Daily Std Dev

IBRX:

97.22%

ACIC:

48.32%

Max Drawdown

IBRX:

-97.14%

ACIC:

-98.73%

Current Drawdown

IBRX:

-93.99%

ACIC:

-48.79%

Fundamentals

Market Cap

IBRX:

$2.20B

ACIC:

$547.34M

EPS

IBRX:

-$0.62

ACIC:

$1.55

PS Ratio

IBRX:

150.22

ACIC:

1.89

PB Ratio

IBRX:

0.00

ACIC:

2.38

Total Revenue (TTM)

IBRX:

$14.71M

ACIC:

$230.06M

Gross Profit (TTM)

IBRX:

$10.57M

ACIC:

-$73.20M

EBITDA (TTM)

IBRX:

-$172.35M

ACIC:

$77.48M

Returns By Period

In the year-to-date period, IBRX achieves a -0.78% return, which is significantly higher than ACIC's -9.80% return.


IBRX

YTD

-0.78%

1M

-16.72%

6M

-51.89%

1Y

-71.68%

5Y*

-6.91%

10Y*

N/A

ACIC

YTD

-9.80%

1M

2.63%

6M

-1.29%

1Y

16.52%

5Y*

9.26%

10Y*

-1.19%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IBRX vs. ACIC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRX
The Risk-Adjusted Performance Rank of IBRX is 1313
Overall Rank
The Sharpe Ratio Rank of IBRX is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of IBRX is 1212
Sortino Ratio Rank
The Omega Ratio Rank of IBRX is 1515
Omega Ratio Rank
The Calmar Ratio Rank of IBRX is 88
Calmar Ratio Rank
The Martin Ratio Rank of IBRX is 1818
Martin Ratio Rank

ACIC
The Risk-Adjusted Performance Rank of ACIC is 6262
Overall Rank
The Sharpe Ratio Rank of ACIC is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of ACIC is 6262
Sortino Ratio Rank
The Omega Ratio Rank of ACIC is 5959
Omega Ratio Rank
The Calmar Ratio Rank of ACIC is 6464
Calmar Ratio Rank
The Martin Ratio Rank of ACIC is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IBRX vs. ACIC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and American Coastal Insurance Corp (ACIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for IBRX, currently valued at -0.70, compared to the broader market-2.00-1.000.001.002.003.00
IBRX: -0.70
ACIC: 0.33
The chart of Sortino ratio for IBRX, currently valued at -1.04, compared to the broader market-6.00-4.00-2.000.002.004.00
IBRX: -1.04
ACIC: 0.88
The chart of Omega ratio for IBRX, currently valued at 0.88, compared to the broader market0.501.001.502.00
IBRX: 0.88
ACIC: 1.11
The chart of Calmar ratio for IBRX, currently valued at -0.72, compared to the broader market0.001.002.003.004.005.00
IBRX: -0.72
ACIC: 0.30
The chart of Martin ratio for IBRX, currently valued at -1.23, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
IBRX: -1.23
ACIC: 1.00

The current IBRX Sharpe Ratio is -0.70, which is lower than the ACIC Sharpe Ratio of 0.33. The chart below compares the historical Sharpe Ratios of IBRX and ACIC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00December2025FebruaryMarchAprilMay
-0.70
0.33
IBRX
ACIC

Dividends

IBRX vs. ACIC - Dividend Comparison

IBRX has not paid dividends to shareholders, while ACIC's dividend yield for the trailing twelve months is around 4.28%.


TTM20242023202220212020201920182017201620152014
IBRX
ImmunityBio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ACIC
American Coastal Insurance Corp
4.28%0.00%0.00%5.66%5.53%4.20%1.90%1.44%1.39%1.52%1.17%0.73%

Drawdowns

IBRX vs. ACIC - Drawdown Comparison

The maximum IBRX drawdown since its inception was -97.14%, roughly equal to the maximum ACIC drawdown of -98.73%. Use the drawdown chart below to compare losses from any high point for IBRX and ACIC. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%December2025FebruaryMarchAprilMay
-93.99%
-38.81%
IBRX
ACIC

Volatility

IBRX vs. ACIC - Volatility Comparison

ImmunityBio, Inc. (IBRX) has a higher volatility of 25.58% compared to American Coastal Insurance Corp (ACIC) at 8.25%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than ACIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay
25.58%
8.25%
IBRX
ACIC

Financials

IBRX vs. ACIC - Financials Comparison

This section allows you to compare key financial metrics between ImmunityBio, Inc. and American Coastal Insurance Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
7.55M
79.27M
(IBRX) Total Revenue
(ACIC) Total Revenue
Values in USD except per share items